Table 1.

Production of Cytokines During Induction of MUC1-Specific CTL Using Peptide-Pulsed DC

No Peptide M1.1 Peptide +PADRE*
IL-12 (pg/mL) 43.3 ± 17  349 ± 140  786 ± 62  
IFN-γ (pg/mL)  0.8 ± 1.2  16.8 ± 1.6  33 ± 9.5 
TNF-α (pg/mL)  36.8 ± 5.5  205 ± 17 306 ± 21  
IL-10 (pg/mL)  17.2 ± 2.2  24 ± 4.2 32 ± 1.9  
IL-6 (pg/mL)  2.4 ± 1.7  6.5 ± 3.5 16 ± 4.6  
sIL-2R (U/mL)  56.8 ± 8.1  201 ± 26 304 ± 39 
No Peptide M1.1 Peptide +PADRE*
IL-12 (pg/mL) 43.3 ± 17  349 ± 140  786 ± 62  
IFN-γ (pg/mL)  0.8 ± 1.2  16.8 ± 1.6  33 ± 9.5 
TNF-α (pg/mL)  36.8 ± 5.5  205 ± 17 306 ± 21  
IL-10 (pg/mL)  17.2 ± 2.2  24 ± 4.2 32 ± 1.9  
IL-6 (pg/mL)  2.4 ± 1.7  6.5 ± 3.5 16 ± 4.6  
sIL-2R (U/mL)  56.8 ± 8.1  201 ± 26 304 ± 39 
*

For CTL induction, DC were pulsed with the synthetic MUC1 peptide M1.1 and incubated with autologous PBMNC in RP10 medium. To analyze the effect of a helper epitope on antigen-specific CTL induction, DC were further incubated with a Pan-HLA-DR binding peptide PADRE in addition to the HLA-A2–binding antigenic peptides. After 5 days of culture, cytokine concentrations in the supernatants were determined using commercially available ELISAs. Experiments were performed in triplicates and the results are expressed as the mean ± SD.

Close Modal

or Create an Account

Close Modal
Close Modal